Recent updates on treatment for pediatric migraine.
10.5124/jkma.2017.60.2.118
- Author:
Kon Hee LEE
1
Author Information
1. Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University School of Medicine, Seoul, Korea. headaches77@gmail.com
- Publication Type:Original Article
- Keywords:
Pediatric migraine;
Child;
Adolescent;
Therapeutics
- MeSH:
Adolescent;
Adult;
Botulinum Toxins;
Calcitonin Gene-Related Peptide;
Child;
Humans;
Korea;
Migraine Disorders*
- From:Journal of the Korean Medical Association
2017;60(2):118-125
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pediatric migraine is a disorder that significantly interferes with the everyday life and school life of approximately 8% of children and adolescents in Korea. Recently, studies on migraine have been carried out very rapidly, many drugs have been developed, and acute-phase and preventive treatments for migraine have been evaluated. Therefore, it is necessary to understand the diagnostic criteria and degree of impairment in pediatric migraine and to become familiar with up-to-date treatment methods in children. Research into the use of botulinum toxin or calcitonin gene-related peptide antagonists to treat adult migraine headaches is progressing, and we expect these therapies to be applicable to pediatric patients soon. Many students in our country are suffering from migraines in their daily life. Therefore, we need to acquire the relevant knowledge and identify practical treatment methods for pediatric migraine in children and adolescents in order to reduce their pain.
